Vaishali Bagalkot
Affiliations: | University of Washington, Seattle, Seattle, WA |
Google:
"Vaishali Bagalkot"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Bagalkot V, Deiuliis JA, Rajagopalan S, et al. (2016) "Eat me" imaging and therapy. Advanced Drug Delivery Reviews |
Bagalkot V, Badgeley MA, Kampfrath T, et al. (2015) Hybrid nanoparticles improve targeting to inflammatory macrophages through phagocytic signals. Journal of Controlled Release : Official Journal of the Controlled Release Society. 217: 243-55 |
Maiseyeu A, Bagalkot V. (2014) In vitro uptake of apoptotic body mimicking phosphatidylserine-quantum dot micelles by monocytic cell line. Nanoscale Research Letters. 9: 176 |
Probst CE, Zrazhevskiy P, Bagalkot V, et al. (2013) Quantum dots as a platform for nanoparticle drug delivery vehicle design. Advanced Drug Delivery Reviews. 65: 703-18 |
Bagalkot V, Gao X. (2011) siRNA-aptamer chimeras on nanoparticles: preserving targeting functionality for effective gene silencing. Acs Nano. 5: 8131-9 |
Bagalkot V, Lee IH, Yu MK, et al. (2009) A combined chemoimmunotherapy approach using a plasmid-doxorubicin complex. Molecular Pharmaceutics. 6: 1019-28 |
Wang AZ, Bagalkot V, Vasilliou CC, et al. (2008) Superparamagnetic iron oxide nanoparticle-aptamer bioconjugates for combined prostate cancer imaging and therapy. Chemmedchem. 3: 1311-5 |
Bagalkot V, Zhang L, Levy-Nissenbaum E, et al. (2007) Quantum dot-aptamer conjugates for synchronous cancer imaging, therapy, and sensing of drug delivery based on bi-fluorescence resonance energy transfer. Nano Letters. 7: 3065-70 |
Zhang L, Radovic-Moreno AF, Alexis F, et al. (2007) Co-delivery of hydrophobic and hydrophilic drugs from nanoparticle-aptamer bioconjugates. Chemmedchem. 2: 1268-71 |
Bagalkot V, Farokhzad OC, Langer R, et al. (2007) Aptamer-dox conjugates as novel platform for targeted drug delivery and imaging Nanomedicine: Nanotechnology, Biology and Medicine. 3: 352 |